PR status is a more decisive factor in efficacy of adding pertuzumab into neoadjuvant therapy for HER2-positive and lymph node-positive breast cancer than ER status: a real-world retrospective study in China.
Journal Information
Full Title: World J Surg Oncol
Abbreviation: World J Surg Oncol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: General Surgery
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateThis retrospective study was approved by the ethics committee of Shandong Frist Medical University and Shandong Academy of Medical Sciences (SDTHEC2022002006) and have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."
"Funding Not applicable."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025